Venus Medtech (Hangzhou) Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 415.86 million compared to CNY 276.05 million a year ago. Net loss was CNY 373.64 million compared to CNY 181.99 million a year ago.

Basic loss per share from continuing operations was CNY 0.85 compared to CNY 0.45 a year ago.